60(top 2%)
papers
2.5K(top 1%)
citations
23(top 1%)
h-index
51(top 1%)
g-index
66
all documents
2.7K
doc citations
969
citing journals

Top Articles

#TitleJournalYearCitations
1Managing Cancer Care During the COVID-19 Pandemic: Agility and Collaboration Toward a Common GoalJournal of the National Comprehensive Cancer Network: JNCCN2020401
2Quantitative Fluoroestradiol Positron Emission Tomography Imaging Predicts Response to Endocrine Treatment in Breast CancerJournal of Clinical Oncology2006357
3Treatment of metastatic melanoma: an overviewOncology2009297
4Interprofessional Communication Skills Training for Serious Illness: Evaluation of a Small-Group, Simulated Patient InterventionJournal of Palliative Medicine2014116
5High-Dose [131I]Tositumomab (anti-CD20) Radioimmunotherapy and Autologous Hematopoietic Stem-Cell Transplantation for Adults ≥ 60 Years Old With Relapsed or Refractory B-Cell LymphomaJournal of Clinical Oncology2007112
6Serial 2-[18F] fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) to monitor treatment of bone-dominant metastatic breast cancer predicts time to progression (TTP)Breast Cancer Research and Treatment200797
7Residual proliferative cancer burden to predict long-term outcome following neoadjuvant chemotherapyAnnals of Oncology201595
8Treatment of Recurrent Squamous Cell Carcinoma of the Skin With CetuximabArchives of Dermatology200792
9PTCy-based haploidentical vs matched related or unrelated donor reduced-intensity conditioning transplant for DLBCLBlood Advances201992
10Gene expression pathway analysis to predict response to neoadjuvant docetaxel and capecitabine for breast cancerBreast Cancer Research and Treatment201090
11Molecular alterations of the IDH1 gene in AML: a Children's Oncology Group and Southwest Oncology Group studyLeukemia201087
12Idelalisib is effective in patients with high-risk follicular lymphoma and early relapse after initial chemoimmunotherapyBlood201768
13Avelumab maintenance in advanced urothelial carcinoma: biomarker analysis of the phase 3 JAVELIN Bladder 100 trialNature Medicine202165
14On the use of lonafarnib in myelodysplastic syndrome and chronic myelomonocytic leukemiaLeukemia200858
15Identifying Elements of ICU Care That Families Report as Important But UnsatisfactoryChest201252
16Discussing Religion and Spirituality Is an Advanced Communication Skill: An Exploratory Structural Equation Model of Physician Trainee Self-RatingsJournal of Palliative Medicine201249
17A New Prognostic Model in Patients with Advanced Urothelial Carcinoma Treated with First-line Immune Checkpoint InhibitorsEuropean Urology Oncology202139
18Immune-related adverse events with PD-1 versus PD-L1 inhibitors: a meta-analysis of 8730 patients from clinical trialsFuture Oncology202139
19Advances in molecular imaging for breast cancer detection and characterizationBreast Cancer Research201232
20Self-Assessment Scores Improve After Simulation-Based Palliative Care Communication Skill WorkshopsAmerican Journal of Hospice and Palliative Medicine201832
21Medullary Thyroid Cancer: Options for Systemic Therapy of Metastatic Disease?Journal of Clinical Oncology200630
22Patient assistance programs: a valuable, yet imperfect, way to ease the financial toxicity of cancer careSeminars in Hematology201827
23Phase II evaluation of an intensified induction therapy with standard daunomycin and cytarabine followed by high dose cytarabine for adults with previously untreated acute myeloid leukemia: A southwest oncology group study (SWOG‐9500)American Journal of Hematology200726
24No evidence of excess breast cancer risk among mutation-negative women from BRCA mutation-positive familiesBreast Cancer Research and Treatment201126
25Utilization of systemic therapy for treatment of advanced urothelial carcinoma: Lessons from real world experienceCancer Treatment and Research Communications202124
26Safety of immune checkpoint inhibitors in patients with cancer and pre-existing autoimmune diseaseAnnals of Translational Medicine202123
27Positron emission tomography imaging as a cancer biomarkerExpert Review of Molecular Diagnostics200721
28Early objective response to avelumab treatment is associated with improved overall survival in patients with metastatic Merkel cell carcinomaCancer Immunology, Immunotherapy201921
29Test–Retest Reproducibility of 18F-FDG PET/CT Uptake in Cancer Patients Within a Qualified and Calibrated Local NetworkJournal of Nuclear Medicine201921
3018F-Fluoroestradiol PET Imaging in a Phase II Trial of Vorinostat to Restore Endocrine Sensitivity in ER+/HER2− Metastatic Breast CancerJournal of Nuclear Medicine202120
31FDG PET-CT in follicular lymphoma: a case-based evidence reviewBlood201519
321239P ORCHARD osimertinib + savolitinib interim analysis: A biomarker-directed phase II platform study in patients (pts) with advanced non-small cell lung cancer (NSCLC) whose disease has progressed on first-line (1L) osimertinibAnnals of Oncology202119
33Emerging Roles for Mammalian Target of Rapamycin (mTOR) Complexes in Bladder Cancer Progression and TherapyCancers202218
34Plasmacytoid Urothelial Carcinoma: Response to Chemotherapy and Oncologic OutcomesBladder Cancer202016
35Randomized phase 2 therapeutic equivalence study of abiraterone acetate fine particle formulation vs. originator abiraterone acetate in patients with metastatic castration-resistant prostate cancer: The STAAR studyUrologic Oncology: Seminars and Original Investigations201815
36National Cancer Institute Combination Therapy Platform Trial with Molecular Analysis for Therapy Choice (ComboMATCH)Clinical Cancer Research202314
37Association between Physician Trainee Self-Assessments in Discussing Religion and Spirituality and Their Patients' ReportsJournal of Palliative Medicine201412
38Duration of Targeted Therapy in Patients With Advanced Non–small-cell Lung Cancer Identified by Circulating Tumor DNA AnalysisClinical Lung Cancer202011
3918F-fluorodeoxyglucose (FDG) PET or 18F-fluorothymidine (FLT) PET to assess early response to aromatase inhibitors (AI) in women with ER+ operable breast cancer in a window-of-opportunity studyBreast Cancer Research202111
40Indications for Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia in the Genomic EraAmerican Society of Clinical Oncology Educational Book / ASCO American Society of Clinical Oncology Meeting20149
41Monoclonal antibodies conjugated with radioisotopes for the treatment of non-Hodgkin's lymphomaSeminars in Oncology Nursing20027
42Sarcomatoid Urothelial Carcinoma: A Population-Based Study of Clinicopathologic Characteristics and Survival OutcomesClinical Genitourinary Cancer20227
43Adjuvant Systemic Therapies for Patients with Renal Cell Carcinoma: Choosing Treatment Based on Patient-level CharacteristicsEuropean Urology Oncology20226
44Cost-effectiveness analysis of neoadjuvant immune checkpoint inhibition vs. cisplatin-based chemotherapy in muscle invasive bladder cancerUrologic Oncology: Seminars and Original Investigations20216
45A phase 2 study of the aurora kinase A inhibitor alisertib for patients with neuroendocrine prostate cancer (NEPC)Annals of Oncology20165
46A digital health intervention to improve nutrition and physical activity in breast cancer survivors: Rationale and design of the Cook and Move for Your Life pilot and feasibility randomized controlled trialContemporary Clinical Trials20225
47A phase I trial of bortezomib in combination with everolimus for treatment of relapsed/refractory non-Hodgkin lymphomaLeukemia and Lymphoma20184
48Wound Complications in Head and Neck Squamous Cell Carcinomas After Anti–PD‐1 TherapyLaryngoscope20194
49Chemoimmunotherapy in urothelial cancer: concurrent or sequential?Lancet Oncology, The20214
50Abstract PD8-01: Phase 3 SOPHIA study of margetuximab (M) + chemotherapy (CTX) vs trastuzumab (T) + CTX in patients (pts) with HER2+ metastatic breast cancer (MBC) after prior anti-HER2 therapies: Final overall survival (OS) analysisCancer Research20224